INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/06/2022
Back to search
Official data from USPTO
VIWIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
11/06/2022
Trademark type
Combined
Nice classes
1, 5
Filing date
04/27/2011
Registration date
05/29/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2022
Last transaction
01/10/2022
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
Shanghai, CN
Examiner
SEVERSON, KAREN
Law office
M80
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the wording "VIWIT" in stylized font.
Holders and representatives
Holders
Viwit Pharmaceutical Co., Ltd.
Viwit Pharmaceutical Co., Ltd.
Representatives
Cecilia R. Dickson The Webb Law Firm
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Adhesives for industrial purposes; chemical products for glazing leather; chemical substances for preserving foodstuffs; fertilizers; epoxy resinsunprocessed; biochemical catalysts; chemical additives to insecticides; industrial chemicals ; agglutinants for concrete; alcohol for industrial purposes
Class 5
Medicines for human purposes for the treatment of respiratory system diseases; medicines for human purposes for the treatment of urinary system diseases; medicines for human purposes for the treatment of nervous system diseases; medicines for human purposes for the treatment of cardiovascular and cerebral system diseases and disorders; medicines for human purposes for the treatment of digestive system diseases; medicines for human purposes for the treatment of endocrine system diseases; medicines for human purposes for the treatment of immunity system diseases and disorders; medicines for human purposes for the treatment of cancer malignancy; radioactive substances for medical purposes; gases for medical purposes; sterilizing reparations; solutions for use with contact lenses; dietetic foods adapted for medical purposes; medicines for veterinary purposes for the treatment of skin disorders ; medicines for veterinary purposesbacterial and bacteriological preparationsblood substitutediagnostic preparationsnucleic acid sequences and chemical reagentspain relief medicationvaccinesferments; insecticides; teeth filling material; depuratives for the body
Publications
History of USPTO decisions and trademark events.
43 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/01/2022
INPC
INVALIDATION PROCESSED
09/30/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/10/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/10/2022
71AG
REGISTERED-SEC.71 ACCEPTED
01/10/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/06/2022
PUM1
OFFICE ACTION ISSUED POU1
07/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/05/2021
ES71
TEAS SECTION 71 RECEIVED
07/01/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/29/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/27/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/23/2018
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
10/23/2018
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
10/23/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2018
ES71
TEAS SECTION 71 RECEIVED
05/29/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
05/25/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/16/2013
FIMP
FINAL DISPOSITION PROCESSED
02/16/2013
GPNX
NOTIFICATION PROCESSED BY IB
11/25/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2012
PUBO
PUBLISHED FOR OPPOSITION
03/13/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2012
NPUB
NOTICE OF PUBLICATION
02/22/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/07/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/02/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2012
ALIE
ASSIGNED TO LIE
01/30/2012
PAPER RECEIVED
01/18/2012
RFNT
REFUSAL PROCESSED BY IB
08/27/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2011
RFRR
REFUSAL PROCESSED BY MPU
08/10/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2011
CNRT
NON-FINAL ACTION WRITTEN
08/09/2011
DOCK
ASSIGNED TO EXAMINER
08/08/2011
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/01/2011
Continuous trademark protection
Get notified about every new filing that threatens VIWIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.